Merit Medical Systems, Inc. MMSI
As ofNov 20, 2026, 12:39 PM EST
- YTD
- -4.14%
- 1 year
- -0.46%
5D -2.54 (-2.92%)
- Market cap
- 5.06B
- Revenue (ttm)
- 1.61B
- Profit margin
- 9.94%
- EPS (ttm)
- 2.67
- Shares out
- 59.92M
- P/E ratio
- 31.62
- Forward P/E
- 18.08
- YTD return
- -4.14%
- 1-year return
- -0.46%
- 50-day average
- 87.87
- Volume
- 153.03K
- Avg volume
- 654.43K
- Open
- 84.58
- Previous close
- 84.41
- Day's range
- 84.20 – 86.20
- 52-week range
- 59.74 – 94.85
- Beta
- 0.55
- Analysts
- Buy
- Price target
- 107.00 (+26.6%)
- Earnings date
- Feb 23, 2027
Key statistics
- 200-day average
- 77.29
- Enterprise value
- 5.47B
- PEG ratio
- 1.53
- Price / sales
- 3.14
- Price / book
- 2.90
- Revenue growth
- 8.40%
- Free cash flow
- 166.63M
- Total cash
- 503.55M
- Total debt
- 822.06M
- Return on equity
- 9.78%
- Short % of float
- 9.01%
Fundamental scorecard
18 of 25 checks passed on MMSI’s reported financials
18of 25 checks passed
- Value 4 of 5
- Growth 5 of 5
- Profitability 4 of 5
- Financial health 5 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: buy
- Target (low)
- 90.00
- Target (mean)
- 107.00
- Target (high)
- 123.00
- Strong buy5
- Buy4
- Hold3
- Sell0
- Strong sell0
Next earnings
Feb 23, 2027
Expected Feb 23, 2027. Consensus EPS estimate 1.10.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 23, 2027 | Dec 30, 2026 | 1.11 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 1.04 | 1.12 | +0.08 | +7.69% |
| Jul 30, 2026 | Jun 30, 2026 | 0.959 | 1.19 | +0.23 | +24.09% |
| Apr 30, 2026 | Mar 31, 2026 | 0.84 | 0.94 | +0.10 | +11.90% |
| Feb 24, 2026 | Dec 31, 2025 | 0.96 | 1.04 | +0.08 | +8.33% |
| Oct 30, 2025 | Sep 30, 2025 | 0.82 | 0.92 | +0.10 | +12.20% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 12, 2026 | Freedom Capital Markets | main | Hold | Hold |
| Oct 30, 2026 | Canaccord Genuity | main | Buy | Buy |
| Oct 30, 2026 | JP Morgan | main | Overweight | Overweight |
| Oct 30, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Oct 30, 2026 | Needham | main | Buy | Buy |
| Oct 30, 2026 | BTIG | main | Buy | Buy |
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; kits and accessories for endoscopy and bronchoscopy procedures; and temporary pacing technology. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- merit.com
News
Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $121
JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $110
Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $92
These Analysts Boost Their Forecasts On Merit Medical Systems After Strong Q3 Results Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $106
BTIG Maintains Buy on Merit Medical Systems, Raises Price Target to $110
Merit Medical Systems Q3 2026 Earnings Call Transcript Merit Medical Systems Acquires Solo Pace For ~$45M
Merit Medical Systems Raises FY2026 Adj EPS Guidance from $4.25-$4.35 to $4.33-$4.37 vs $4.30 Est; Narrows FY2026 Sales Guidance from $1.631B-$1.643B to $1.635B-$1.642B vs $1.636B Est
Merit Medical Systems Q3 Adj. EPS $1.12 Beats $1.03 Estimate, Sales $416.244M Beat $410.376M Estimate
Your note
Sign in to keep a note on MMSI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ARONSON MARTHA GOLDBERG | Chief Executive Officer | Purchase | May 5, 2026 | 49,792 |
| CARPENTER LONNY J | Director | Stock Award(Grant) | May 17, 2026 | 20,824 |
| GUNDERSON THOMAS JAMES | Director | Conversion of Exercise of derivative security | May 19, 2026 | 60,741 |
| LAMPROPOULOS FRED P | Officer and Director | Sale | Nov 24, 2025 | 1,126,460 |
| LLOYD BRIAN G | Officer | Sale | Nov 15, 2026 | 62,132 |
| MILLNER F ANN | Director | Stock Award(Grant) | May 17, 2026 | 38,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.84% | 9,492,223 | 801.24M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 5.71% | 3,422,076 | 288.86M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.32% | 2,591,018 | 218.71M | Sep 29, 2026 |
| State Street Corporation | 4.10% | 2,457,916 | 207.47M | Sep 29, 2026 |
| Fuller & Thaler Asset Management Inc. | 3.60% | 2,155,047 | 181.91M | Sep 29, 2026 |
| Dimensional Fund Advisors LP | 2.76% | 1,655,196 | 139.72M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.94% | 3,556,402 | 300.20M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.01% | 1,802,360 | 152.14M | Jun 29, 2026 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 2.58% | 1,543,773 | 130.31M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.57% | 1,542,648 | 130.21M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.17% | 1,299,239 | 109.67M | Jun 29, 2026 |
| Conestoga Funds-Conestoga Small Cap Fund | 1.60% | 958,075 | 80.87M | Jun 29, 2026 |
